Pharmaust Limited (ASX:PAA) shares fell 4.5% during mid-day trading on Tuesday . The stock traded as low as A$0.11 ($0.07) and last traded at A$0.11 ($0.07), 75,851 shares were traded during mid-day trading. The stock had previously closed at A$0.11 ($0.08).
The company has a current ratio of 3.28, a quick ratio of 2.59 and a debt-to-equity ratio of 4.35. The stock has a 50 day moving average of A$0.12. The stock has a market capitalization of $31.69 million and a price-to-earnings ratio of -15.00.
About Pharmaust (ASX:PAA)
PharmAust Limited operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer.
Featured Article: What is a Real Estate Investment Trust (REIT)?
Receive News & Ratings for Pharmaust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmaust and related companies with MarketBeat.com's FREE daily email newsletter.